CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Torsten Lowin

OPENALEX: A5059827989↗ORCID: 0000-0001-7368-2776↗

Affiliations

Organizations

Düsseldorf University Hospitalauthorship · DE Heinrich Heine University Düsseldorfauthorship · DE

Public evidence

5 connected articles

Anti-Inflammatory Effects of Cannabigerol in Rheumatoid Arthritis Synovial Fibroblasts and Peripheral Blood Mononuclear Cell Cultures Are Partly Mediated by TRPA1.2023 · Europe PMC Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts.2020 · PubMed Central Open Access The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets.2016 · Europe PMC Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis.2015 · Europe PMC Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner.2015 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Torsten Lowin - Medical Cannabis Research Engine